Let's Know! for Speech Delay

Age: < 18

Sex: Any

Trial Phase: Academic

Sponsor: Arizona State University

Disqualifiers: English-Language Learner services

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

Duration: 10 weeks

22 Participants Needed

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether participants must stop taking their current medications.

What data supports the effectiveness of the treatment Let's Know! for speech delay?

The research suggests that direct therapy can lead to better speech outcomes and higher caregiver satisfaction compared to advice or online resources, indicating that structured interventions may be effective for speech delays. ^{1 2 3 4 5}

How is the treatment Let's Know! unique for speech delay?

The Let's Know! treatment for speech delay is unique because it focuses on early intervention and structured management to improve speech and language outcomes, which is crucial for preventing negative impacts on literacy and social development. Unlike some approaches that may delay action, Let's Know! emphasizes timely detection and intervention to address the underlying causes of speech delay. ^{6 7 8 9 10}

What is the purpose of this trial?

Oral language skills are vital for reading comprehension. Some children, however, are at increased risk for reading comprehension difficulties due to underlying oral language deficits. School-based interventions that target children's abilities to understand and produce spoken language have shown positive effects for improving language and reading comprehension of children with typical development and those at-risk for language disorders, so it is likely that they will benefit children with low oral language skills. The purpose of this study is to examine the efficacy of a small-group intervention for improve language skills in first grade students with low oral language skills.

Eligibility Criteria

This trial is for first grade students who struggle with oral language skills, which may affect their reading comprehension. It's designed to help those at risk for Central Auditory Processing Disorder, Acquired Language Disorder, or Speech Delay.

Inclusion Criteria

No hearing impairment

Receive a score of below than 5 on two items on the Student Language Scale (Nelson et al., 2018) or be receiving school speech-language services for language impairment

Proficient in English, per caregiver report

Exclusion Criteria

Cannot be enrolled in English-Language Learner services in the school.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive a 10-week small-group multi-component intervention to improve vocabulary, text structure knowledge, inferencing, and comprehension monitoring

10 weeks

Follow-up

Participants are monitored for language comprehension outcomes after the intervention

4 weeks

Treatment Details

Interventions

• Let's Know!

Trial Overview The study tests 'Let's Know!', a small-group intervention aimed at improving the spoken language abilities of children with low oral language skills to enhance their reading comprehension.

Participant Groups

Group I: Intervention Experimental Treatment 1 Intervention

2 units of a multicomponent intervention to improve vocabulary, text structure knowledge, inferencing, and comprehension monitoring within narrative and expository texts.

Who Is Running the Clinical Trial?

Arizona State University

Lead Sponsor

Trials

311

Recruited

109,000+

Findings from Research

Speech motor control involves complex systems that manage how we plan and execute speech movements, which is crucial for understanding communication disorders like motor speech disorders.

There is ongoing debate about whether disorders such as apraxia of speech and stuttering should be viewed primarily through the lens of motor control or phonologic processes, highlighting the need for a comprehensive approach to treatment and understanding.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Research on speech motor control and its disorders: a review and prospective. Kent, RD.[2019]

References

1. England pubmed.ncbi.nlm.nih.gov

Randomised controlled trial of community based speech and language therapy in preschool children. [2022]

2. United States pubmed.ncbi.nlm.nih.gov

Patient-Reported Outcomes and Evidence-Based Practice in Speech-Language Pathology. [2021]

3. United States pubmed.ncbi.nlm.nih.gov

Integration of the Cleft-Q Patient Reported Outcome Tool into a Multidisciplinary Cleft and Craniofacial Clinic: A Proof of Concept. [2023]

4. United States pubmed.ncbi.nlm.nih.gov

Measuring Stakeholder Perceptions: A Review of Social Validity Reporting in ASHA Journals. [2021]

5. England pubmed.ncbi.nlm.nih.gov

Waiting for speech-language pathology services: A randomised controlled trial comparing therapy, advice and device. [2021]

6. United States pubmed.ncbi.nlm.nih.gov

Evaluation and management of the child with speech delay. [2022]

7. Brazil pubmed.ncbi.nlm.nih.gov

Health sciences descriptors in the brazilian speech-language and hearing science. [2019]

8. England pubmed.ncbi.nlm.nih.gov

12 minute consultation: An evidence-based approach to the management of a child with speech and language delay. [2013]

9. United States pubmed.ncbi.nlm.nih.gov

Research on speech motor control and its disorders: a review and prospective. [2019]

10. France pubmed.ncbi.nlm.nih.gov

[Early diagnosis of language disorders]. [2006]